| Name | Title | Contact Details |
|---|---|---|
Petra Strojilova |
Deputy Head of NA Cyber | Profile |
At Preciball USA, we have provided tailored precision and industrial balls to a wide variety of industries for nearly 100 years. This long standing commitment to excellence and dedication to our customers has earned us advanced expertise and a thorough understanding of hundreds of very specific applications and processes in industries around the globe. Our products are used in applications such as bearings, pumps, valves, swivel joints, transfer units, casters, oil and gas extraction, grinding and dispersion, sprayers, conveyors, and agitators... Materials include carbon, chrome, stainless steel, plastic, glass, phenolic resin, and exotic alloys. Our capabilities include engineering, research and development, custom product development and manufacturing.
Fouts Bros is a fire apparatus manufacturer based in Milledgeville, GA. We are family owned and operated since 1952. We are always looking for talented individuals to join our team! Submit your resumé at foutsfire.com.
Health In Tech is an insurtech company focused on enhancing the self-funding process in the healthcare sector. The company aims to create efficient and innovative solutions that benefit individuals and businesses while improving the health insurance landscape. It operates a dynamic marketplace that utilizes third-party AI technology to deliver customized solutions. The company offers a variety of proprietary digital platforms and services that streamline the quoting and underwriting processes for brokers, third-party administrators, and insurers. Key offerings include reference-based pricing, group insurance captives, community health plans, and the eDIYBS platform for small and medium-sized employers. Additionally, the Health Intelligence Card and HI Performance Network are designed to improve the management of medical records and claims while providing cost-effective healthcare options. Health In Tech, Inc. is publicly traded on NASDAQ under the ticker symbol HIT and was founded in 2014. The company is led by CEO Tim Johnson and has around 80 employees.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
ABB is a technology leader in electrification and automation, enabling a more sustainable and resource-efficient future. The companys solutions connect engineering know-how and software to optimize how things are manufactured, moved, powered and operated. Building on over 140 years of excellence, ABBs more than 105,000 employees are committed to driving innovations that accelerate industrial transformation. www.abb.com Privacy notice & house rules: https://social.abb/social-media-information Before applying for a job at ABB, please read our Fraud Warning: https://careers.abb/global/en/fraud-warning